FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

12 letters match. Newest first.

  1. Nipro Renal Solutions USA, Corporation

    Nipro Renal Solutions USA released hemodialysis dialysate lots with out-of-spec endotoxin (bacterial toxin) and had widespread quality-system failures, FDA says.

    High risk
  2. Technological Medical Advancements LLC

    Technological Medical Advancements LLC marketed Diowave laser systems for unapproved uses without required FDA clearance and had serious quality-system failures.

    High risk
  3. The Richline Group, Inc.

    FDA warns Richline Group over unapproved Inverness ear care products and quality-system failures.

    High risk
  4. NeuroSync, Inc.

    FDA warned NeuroSync, Inc. that its EYE-SYNC eye-assessment device was adulterated by design control, CAPA, supplier and acceptance failures, plus unreported correction and missing UDI.

    High risk
  5. Argon Medical Productions & Vertrieb Gesellschaft MBH & CO

    FDA warns Argon Medical over dental implant quality-system failures, unreported injuries, and missing unique device identifier labeling.

    High risk
  6. Optikem International, Inc.

    FDA cited Optikem International of Denver for unvalidated sterilization and unapproved formulation changes to its Sereine contact lens solutions.

    High risk
  7. AG Essence, Inc.

    FDA warned AG Essence that its Banda-SiL silver wound gels are adulterated and misbranded because they are sold without required FDA marketing clearance.

    High risk
  8. Wello Inc.

    FDA cited Wello Inc. for misbranded welloStationX devices because labels lacked unique device identifiers and required GUDID data were not submitted.

    Low
  9. Caltag Medsystems Ltd

    FDA warned Caltag Medsystems over quality-system failures in making TransFix/EDTA Vacuum Blood Collection Tubes.

    Medium
  10. ZYTO Technologies, Inc.

    FDA warns ZYTO over unapproved disease claims for Hand Cradle GSR and quality-system failures.

    High risk
  11. Forcemech International LLC

    Forcemech International, a powered wheelchair relabeler in Pearland, Texas, lacked quality system procedures and UDI labeling, FDA says.

    Medium
  12. Med Pen Concepts, LLC

    FDA warned Med Pen Concepts about unapproved plasma skin devices and quality-system failures.

    High risk